This study revealed the high expression of the SARS-CoV-2 receptors, ACE2 and TMPRSS2, at resection margins of lung cancer survivors and its possible relationship with the higher susceptibility of these patients to COVID-19. This evidence concerns the gene ACE2 and lung carcinoma.